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Summary. Human neutrophils possess an NADPH oxi- 
dase which catalyzes uperoxide (02) formation and is 
activated by chemotactic peptides. Histamine inhibits 
O2formation via H2-receptors (Burde et al. 1989). We 
characterized the neutrophil H2-receptor with a series 
of new guanidine-type Ha-agonists tructurally derived 
from impromidine. Histamine inhibited 02 formation 
with an ICso value of 6.7 + 1.2 gM. Five aryloxy- and 
arylthioalkylguanidines were less potent and effective 
than histamine. Several arpromidine-like phenyl(py- 
ridylalkyl)guanidines were either full or partial H2- 
agonists. Some guanidines possess athree-membered car- 
bon chain connecting the aromatic rings and the guani- 
dine group; they were similarly potent and effective as 
histamine. Shortening or elongation of the carbon chain 
substantially decreased the potency and intrinsic activity 
of the guanidines. Halogenation of the phenyl ring did 
not substantially affect he potency and intrinsic activity 
of the compounds in comparison to the non-substituted 
parent compound. The H2-antagonist, famotidine, com- 
petitively antagonized inhibition of 02 formation caused 
by the guanidine, arpromidine, with a pAa value of 6.84. 
The H2-antagonist, cimetidine, differentially counteract- 
ed inhibition caused by partial and full H2-agonists. Par- 
tial H2-agonists antagonized the effects of histamine. 
The inhibitor of phosphodiesterases, 3-isobutyl-1- 
methylxanthine, additively enhanced the inhibitory ef- 
fects of histamine and guanidines. The properties of the 
neutrophil Ha-receptor were compared with literature 
data concerning properties of the Ha-receptor of the 
guinea pig atrium. In the latter system, guanidines are 
full H2-agonists with potencies of up to 125-fold of that 
of histamine. Our data indicate that guanidines inhibit 
02 formation in human neutrophils via Ha-receptors. 
The structure/activity relationship for the neutrophil H2- 
receptor substantially differs from the one for the Ha- 
receptor in the guinea pig atrium, suggesting that the 
neutrophil Ha-receptor has cell type-specific properties. 
Send offprint requests to R. Seifert at the above address 
Other possibilities to explain the differences between H2- 
receptors in these systems are discussed. 
Key words: Superoxide formation - Human neutro- 
phils - Arpromidine - Histamine - H2-receptors 
Introduction 
Human neutrophils possess an NADPH oxidase which 
catalyzes superoxide (O~) formation and is activated by 
the chemotactic peptide, N-formyl-L-methionyl-L-leucyl- 
L-phenylalanine (fMet-Leu-Phe) (Rossi 1986; Seifert et 
al, 1989a, b, c). Agents which increase the intracellular 
cAMP concentration, e.g. prostaglandins, adenosine,/~- 
adrenergic agonists and the phosphodiesterase inhibitor, 
3-isobutyl-l-methylxanthine (IBMX), inhibit 02 forma- 
tion (Rossi 1986; Seifert et al. 1989a, b, c; Burde et al. 
1989). In addition, histamine plays an important role 
as intercellular signal molecule in the pathogenesis of
inflammatory processes (Gespach and Abita 1982; 
Seligmann et al. 1983; Burde et al. 1989). Human 
neutrophils possess histamine Ha-receptors, whose 
agonist occupation leads to an increase in cAMP and to 
inhibition of aggregation, lysosomal enzyme release and 
02 formation (Gespach and Abita 1982; Seligmann et 
al. 1983; Burde et al. 1989). In human neutrophils, the 
Ha-agonist, impromidine, is about four-fold more potent 
than histamine with respect to inhibition of O2 formation 
and about 15-fold more potent han histamine with re- 
gard to cAMP accumulation (Gespach and Abita 1982; 
Burde et al. 1989). However, in the guinea pig atrium, 
impromidine is almost 50-fold as potent as histamine with 
respect to positive chronotropy (Durant et al. 1978). In 
contrast, impromidine is a partial agonist in the isolated 
guinea pig papillary muscle, in the isolated stomach of 
the rat, in cultured calf-aorta smooth muscle cells and in 
HL-60 leukemic ells (Parsons and Sykes 1980; Luchins 
and Makman 1980; Bertaccini and Coruzzi 1981; 
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Gespach et al. 1982). In addition, there is evidence that 
H2-receptors in murine lymphocytes, human platelets 
and HL-60 cells possess properties different from those 
of H2-receptors in other cell types, suggesting that Hz- 
receptors in blood cells may be different from those in 
other cell types (Gespach et al. 1986; Khan et al. 1987; 
Mitsuhashi et al. 1989). 
Recently, a series of guanidines structurally related to 
impromidine and possessing Hz-agonistic properties has 
been synthesized (Buschauer 1988a, b,c, 1989). The 
structural formulae of the aryloxy- and arylthioalkyl- 
guanidines I -5 ,  and of the phenyl(pyridylalkyl)- 
guanidines 6 - 17 are shown in Table 1. The latter group 
of compounds represents a new class of very potent posi- 
tive inotropic agents (Buschauer 1989). In addition, phe- 
nyl(pyridylalkyl)guanidines possess H~-antagonistic 
properties (Buschauer 1989). All these results prompted 
us to study the effects of guanidines 1 -17  in human 
neutrophils and to compare their H2-agonistic activity 
with literature data concerning their activity in a standard 
model for the analysis of Hi-receptors, the guinea pig 
right atrium (Black et al. 1972). We here report that 
the Hz-agonistic activity of guanidines 1- 17 in human 
neutrophils ubstantially differs from the one in the 
guinea pig atrium, suggesting that neutrophil Hz-recep- 
tors are different from Hg-receptors in other cell types. 
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Fig. 1. Kinetics of O~ formation in human eutrophils. The effect 
of guanidine 9 (arpromidine) on fMet-Leu-Phe-induced O2-forma- 
tion was studied. Superimposed original registrations from one rep- 
resentative experiment are shown. A, B, C and D indicate the ad- 
dition of fMet-Leu-Phe (1 gM) or compound 9 (1 mM) at different 
times. Trace 1: B, fMet-Lcu-Phe; A and B, compound 9.Trace 2: 
B, fMet-Leu-Phe; C, compound 9. Trace 3: B, fMet-Leu-Phe; D, 
compound 9. Trace4: B, fMet-Leu-Phe. Similar results were 
obtained inthree xperiments carried out with different preparations 
of neutrophils 
Materials and methods 
Materials. Dimaprit, (R)-c~-methylhistamine and guanidines 1-17 
were synthesized as described recently (Kartinos 1964; Gerhard and 
Schunack 1980; Buschauer 1988a, b, c, 1989). Stock solutions of 
these compounds (100 mM each) were prepared in distilled water 
and were stored at -20 ° C. Sources of other materials have been 
described elsewhere (Seifert and Sch~ichtele 1988; Seifert et al. 
1989a, b, c; Burde et al. 1989). 
Isolation oJneutrophils. Human eutrophils were isolated from buffy 
coat preparations obtained from the local blood bank by dextran 
sedimentation a d centrifugation through Ficoll-Hypaque (Seifert 
et al. 1989b). Cell preparations consisted of more than 98% viable 
neutrophils a  judged by trypan blue dye exclusion and Pappenheim- 
stained smears. 
Assay for superoxide formation. O~ formation was monitored by 
continuous measurement of ferricytochrome C reduction i hibitable 
by superoxide dismutase, using an Uvikon 810 dual-beam 
spectrophotometer (Kontron, Eching, FRG) (Seifert et al. 
1989 a, b, c; Burde et al. 1989). Reaction mixtures (0.5 ml) contained 
1.0 x 106 neutrophils, 100 gM ferricytochrome C and a buffer con- 
sisting of (mM) 138 NaC1, 6 KC1, i MgC12, 1 CaC12, 5.5 glucose 
and 20 Hepes/NaOH, pH 7.4. Reaction mixtures were preincubated 
for 5 min at 37°C in the presence of the substances indicated. Reac- 
tions were initiated by the addition of fMet-Leu-Phe (1 gM). The 
absolute amounts of O~ generated were calculated. 
Results 
The effect of guanidine 9 (arpromidine) on O~ formation 
in human neutrophils was studied. Figure 1 shows super- 
imposed kinetic registrations of O~ formation, fMet- 
Leu-Phe reversibly activated O~ formation which ceased 
after 6 min (trace 4). When added 5 min prior to or simul- 
taneously with fMet-Leu-Phe, compound 9 at 1 mM in- 
hibited OF formation by about 60% (trace 1). In addi- 
tion, compound 9 rapidly terminated O~ formation when 
added 30 s or 1 min after fMet-Leu-Phe (traces 2 and 3). 
Similar results as with compound 9 were obtained with 
the Hi-agonists, dimaprit and impromidine (data not 
shown). These data show that H2-agonists of various 
chemical classes rapidly inhibit O~ formation as is the 
case for histamine (Burde et al. 1989). 
The effects of various Hi-agonists at concentrations 
between 100 nM and 1 mM on OF formation were stud- 
ied. Similarly to histamine, impromidine and the weak 
partial H2-agonist, ]?-histine (Burde et al. 1989), the Hi- 
agonists analyzed in our present study inhibited OF for- 
mation with sigmoid concentration response functions, 
reaching aplateau at 0.1 - 1 mM (data not shown). None 
of the H2-agonists tudied per se induced O~- formation 
(data not shown). Table 1 summarizes the ICso values 
and intrinsic activities of compounds 1-17,  histamine 
being the reference. In addition, the effects of dimaprit, 
and of the potent H3-agonist and weak partial H2- 
agonist, (R)-c~-methylhistamine (Arrang et al. 1987), on 
OF formation were studied. Histamine inhibited Oy for- 
mation with an ICs0 value of 6.7 gM. In agreement with 
a recent report, dimaprit was less potent but similarly 
effective as histamine to inhibit O~- formation (Seligmann 
et al. 1983). (R)-e-methylhistamine was considerably ess 
potent than histamine and acted as a partial agonist at 
the neutrophil H2-receptor. The guanidines 1, 4 and 5 
were much less potent and effective inhibitors of O~- for- 
mation than histamine. The phenylthioalkylguanidines 2 
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Table 1. Inhibition by various Hz-agonists of fMet-Leu-Phe-stimulated O2 formation i  human eutrophils: Comparison with H2-agonistic 
activity in the isolated guinea-pig right atrium 
H H ~ NH 
X" (Chain) ~ N ,,~ N 
NH 
Compound A R X Chain 
Inhibition of 
fMet-Leu-Phe- 
stimulated 
Oi formation in 
human eutrophils 
IC5o (gM) b i.a. ° 
H2-agonism inthe 
isolated guinea pig 
right atrium a 
rel. pot. d i.a. c 
1 CH H O 
2 CH H S 
3 CH C1 S 
4 N H S 
5 N H S 
CH2CH(OH)CH2 
CH2CH2 
CH2CH2 
CH2CH2 
CH2CH2CH2 
178 ± 47.3 0.37 3,9 1.0 
13 ± 6.4 0.56 5.0 1.0 
9 ± 4.9 0.65 4.0 1.0 
170 ± 51.4 0.49 3.2 1.0 
250 + 2.0 0.70 12.6 1.0 
@.. ,1 /  N~ R H r,  NH (CH 2) n'~/N 
Py NH 
6-12, 14-17 
Py© 
13 
Compound R n Human neutrophils Guinea-pig atrium 
ICs0 (ta, M) b rel. pot. d i.a. c rel. pot. d i.a. c 
6 H 1 145 ± 5.0 (0.05) 0.39 2.2 1.0 
7 H 2 4.0 ± 0.4 1.68 0.79 24.5 1.0 
8 4-CH3 2 8.2 ± 3.4 0.82 0.77 51.3 1.0 
9 (Arpromidine) 4-F 2 10 -~ 1.6 0.67 0.95 102.3 1.0 
10 4-C1 2 2.7 ± 0.9 2.48 0.92 69.2 1.0 
11 4-Br 2 4.4 ± 0.4 1.52 0.89 30.2 1.0 
12 4-CF3 2 5.2 ± 1.1 1.29 0.94 57.5 0.9 
13 4-F 2 8.2 ± 1.8 0.82 0.84 123.0 1.0 
14 3,4-F2 2 3.5 ± 1.6 1.91 0.88 131.8 1.0 
15 3,5-F2 2 3.5 ± 2.3 1.91 0.86 112.2 1.0 
16 2,4-C12 2 7.4 ± 2.7 (0.91) 0.64 52.5 0.9 
17 H 3 183 ± 30 (0.04) 0.44 4.1 1.0 
Histamine 6.7 ± 1.2 1.00 1.00 1.0 1.0 
Dimaprit 23 ± 4.6 0.29 0.89 0.71 1.0 
Impromidine e 2.0 + 0.2 3.35 1.00 48.1 1.0 
(R)-e-Methylhistamine I88 ± 2.3 (0.04) 0.70 0.01 0.8 
The effects of various H2-agonists on O~- formation induced by fMet-Leu-Phe in human eutrophils were studied. H2-agonists or distilled 
water (control) were added to reaction mixtures 5min prior to fMet-Leu-Phe (1gM). In the absence of H2-agonists, neutrophils generated 
5.1 ± 0.6 nmoles of O~/106 cells. "data for the relative potencies and intrinsic activities of compounds 1 -17, dimaprit, impromidine, 
histamine and (R)-e-methylhistamine in the guinea pig atrium were compiled from Parsons et al. (1977); Gerhard and Schunack (1980); 
Arranget al. (1987) and Buschauer (1988 a, b, c, 1989); the ECs0 value for histamine inthe guinea pig atrium is i gM; b data shown are the 
means ± SE of four to seven experiments carried out with different preparations ofneutrophils; ~ intrinsic activity, referred to histamine =
1 ; d relative potency, referred to histamine =1, in parentheses the relative potencies forH2-agonists with intrinsic activity < 0.75 are given; 
e data for the relative potency and intrinsic activity of impromidine were compiled from Burde et al. (1989) 
and 3 possessed similar potencies as histamine but were 
partial agonists, too. The Hz-agonistic activity of the 
arpromidine-l ike phenyl(pyridylalkyl)guanidines i  hu- 
man neutrophi ls trongly depended on the length of the 
carbon chain connect ing the aromatic rings with the 
guanidine group. Compounds  6 and 17 are characterized 
by two- and four-membered carbon chains, respectively, 
and were much less potent and effective than histamine. 
In contrast, guanidines 7 -16  possess a three-membered 
carbon chain and were similarly potent and effective as 
histamine. Halogenat ion of the phenyl ring did not sub- 
stantially affect the potency of guanidines (compare 
guanidine 7 versus guanidines 9 -  12 and 14-16) .  How- 
ever, except 2,4-dichlorination, halogenat ion slightly in- 
creased the intrinsic activity (compare compounds 7 ver- 
sus compounds 9 -11) .  
The interact ion of arpromidine (9) with the potent 
H2-antagonist,  famotidine (Schunack 1987; Fagot  et al. 
1988), was studied (Fig. 2). Famot id ine per se at the 
concentrat ions studied id not affect O~- format ion (data 
not shown). Famot id ine at fixed concentrat ions ranging 
from 0 .3 -10  BM shifted the concentrat ion-response 
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Fig. 2A, B. Effect of the HE-antagonist, famotidine, on inhibition 
of fMet-Leu-Phe-induced 02 formation caused by guanidine 9 
(arpromidine) in human neutrophils. Panel A: The effect of 
famotidine at various fixed concentrations oninhibition of 02 for- 
mation caused by compound 9 was studied. Compound 9 and 
famotidine or distilled water (control) were simultaneously added 
to reaction mixtures. After a preincubation period of 5 rain, 02 
formation was initiated by the addition of fMet-Leu-Phe (1 ~tM). 
The concentrations of famotidine were as follows: 0 gM (O), 
0.3 gM (A), 0.6 gM (11), 1 gM (IF), 5 gM (II,), 10 gM ('e). Data 
shown are the means of assay triplicates of an experiment performed 
with one preparation of neutrophils; these varied by less than 5%. 
Similar results were obtained in two experiments carried out with 
two different preparations of neutrophils. Panel B: Schild plot 
analysis of the data from Panel A. The agonist dose ratios A'/A were 
calculated, A being the concentration f compound 9 producing a
given effect in the absence of famotidine and A' being the concen- 
tration of compound 9 producing a given effect in the presence of 
famotidine at a concentration B. The regression line and the pAE 
value (intercept of the graph with the abscissa) were calculated as 
described (Tallarida nd Jacob 1987) 
curves for compound 9 to the r ight (panel A). These 
data were t ransformed into a Schild plot  (Schild 1947; 
Tal lar ida and Jacob 1987) (panel B). The equat ion for 
the regression line is y = -1 .08  x + 7.41 and the inter- 
cept with the abscissa (i.e. the pA2 value for famotidine) 
Table 2. Antagonism by cimetidine against inhibition of fMet-Leu- 
Phe-induced O2 formation in human neutrophils caused by hista- 
mine and by guanidines 3,7, 8, 10 and 11 
HE-agonist O~- formation (in % of control) 
HE-antagonist 
control cimetidine 
None 100 98 b 
Histamine 61 98" 
Compound 3 80 87 a 
Compound 7 73 89" 
Compound 8 76 94 a 
Compound 10 60 83" 
Compound 11 64 85 a 
The effect of various HE-agonists (10 gM) on 02 formation induced 
by fMet-Leu-Phe (1 gM) in the absence and presence of cimetidine 
(10 ~M) was studied. Hz-agonists and cimetidine or distilled water 
(control) were added to reaction mixtures 5 min prior to fMet- 
Leu-Phe. In the absence of H2-agonists and cimetidine, neutrophils 
generated 4.8 + 0.6 nmoles of O2/106 cells. Data shown are the 
means of five experiments carried out with different preparations of 
neutrophils; these varied by less than 10%. The statistical signifi- 
cance of the effects of cimetidine was assessed using the Wilcoxon 
test. "p < 0.01; b not significant 
Table 3. Effect of aryloxyalkylguanidine 1 and phenyl(pyridyl- 
alkyl)guanidine 17on fMet-Leu-Phe-induced 02 formation in hu- 
man neutrophils: Antagonism against histamine 
Addition 02 formation (in % of control) 
control compound 1 compound 17 
(1 mM) (1 mM) 
None 100 73 70 
Histamine (100 gM) 16 59 72 
The effects of guanidines 1 and 17 and of histamine at the indicated 
concentrations or combinations of these agents on 02 formation 
induced by fMet-Leu-Phe (1 gM) were studied. Histamine and/or 
compounds 1 or 17 or distilled water (control) were added to reac- 
tion mixtures 5 rain prior to fMet-Leu-Phe. In the absence of the 
above substances, fMet-Leu-Phe induced the formation of 
4.5 _+ 0.5 nmoles OfOE/10 6 cells. Data shown are the means of four 
experiments carried out with different preparations ofneutrophils; 
these varied by less than 10% 
is 6.48. These data indicate that famot id ine competit ively 
antagonizes the effects of  guanidine 9 at neutrophi l  HE- 
receptors. 
The interact ion of  var ious other guanidines and hista- 
mine with the HE-antagonist,  c imetidine (Buschauer et 
al. 1989), was studied (Table 2). Cimetidine at 10 gM per 
se did not  affect 02  format ion but abol ished the inhibi- 
tory effect of  h istamine at an equimolar  concentrat ion.  
In addit ion,  c imetidine a lmost  completely antagonized 
inhibit ion o f  O~ format ion caused by guanidine 8 and 
attenuated the effects of  compounds  3, 7, 10 and 11. 
As a variety of  guanidines were found to be part ia l  
agonists at neutrophi l  HE-receptors (e.g. compounds  1- 
6, 16 and 17), we addressed the question whether they 
would act as part ia l  antagonists in the presence of  the full 
agonist,  histamine. In pars pro toto, the interact ion of  
459 
Table 4. Interaction of histamine and compounds 1, 10, 12, and 17 
with IBMX on fMet-Leu-Phe-induced 02 formation in human 
neutrophils 
H2-agonist (1mM) O~ generation (i  % of control) 
control IBMX 
None 100 84* 
Histamine 49 19" 
Compound 1 73 55* 
Compound l 0 54 24* 
Compound 12 43 20* 
Compound 17 65 47* 
The effects of various Hz-agonists in the absence and presence of
IBMX (10 jxM) on O~ formation i duced by fMet-Leu-Phe (1gM) 
were studied. Hz-agonists and IBMX or distilled water (control) 
were added to reaction mixtures 5rain prior to fMet-Leu-Phe. Data 
shown are the means of six experiments carried out with different 
preparations of neutrophils; these varied by less than 10%. The 
statistical significance ofthe effects of IBMX was assessed statisti- 
cally using the Wilcoxon test. *p < 0.01 
guanidines 1 and 17, which possess very low intrinsic 
activity, with histamine was studied (Table 3). In fact, 
compounds 1 and 17 at 1 mM antagonized, at least in 
part, inhibition of O2 formation caused by histamine at 
100 ~tM. 
Finally, the interactions of IBMX with full and partial 
H2-agonists were studied (Table 4). IBMX at a submaxi- 
mally effective concentration (10 gM) inhibited 02 for- 
mation by 16%. In addition, IBMX additively enhanced 
the inhibitory effects of the full H2-agonists, histamine, 
compounds 10 and 12, and of the partial H2-agonists, 
guanidines I and 17, on 02 formation. 
Discussion 
We studied the effects of a series of guanidines on 02 
formation in human neutrophils and found that these 
compounds are either full (e.g. compounds 9-12)  or 
partial (e.g. compounds 1 -6 ,  16 and 17) H2-agonists ( ee 
Tables 1 and 3). The full H2-agonists are similarly potent 
as histamine, and the partial Hz-agonists are either simi- 
larly potent as histamine (compounds 2,3, and 16) or are 
less potent (e.g. compounds 1, 4 and 5). H2-antagonists 
counteract the effects of partial and full H2-agonists, 
and IBMX potentiates the effects of partial and full H2- 
agonists on O2-formation (see Fig. 2 and Tables 2 and 
4). In addition, the potent H3-agonist and weak partial 
H2-agonist, (R)-e-methylhistamine, is much less potent 
than histamine (see Table 1). All these data are in agree- 
ment with recent results howing that human neutrophils 
possess H2-receptors (Gespach and Abita 1982; Gespach 
et al. 1982; Seligmann et al. 1983; Burde et al. 1989; 
Mitsuhashi et al. 1989). 
Substantial evidence has been accumulated that H2- 
receptors are heterogenous in various cell types (Luchins 
and Makman 1980; Parsons and Sykes 1980; Bertaccini 
and Coruzzi 1981, 1983; Gespach et al. 1982, 1986; Khan 
et al. 1987; Buschauer 1989; Mitsuhashi et al. 1989). 
Dissociations in the relative potency and intrinsic activity 
of H2-agonists and differences in the potency of Hz- 
antagonists in various cell types suggest hat subtypes 
of H2-receptors exist (Bertaccini and Coruzzi 1983; 
Gespach et al. 1986). In order to answer the question of 
whether neutrophils possess cell-type specific H2-recep- 
tors, we compared the structure/activity relationship of 
H2-agonists in these cells with that in the guinea pig right 
atrium. The data concerning the properties of the Ha- 
receptor in the guinea pig atrium were taken from the 
literature and were obtained by us or by other groups of 
investigators (see Table 1). A disadvantage of our ap- 
proach may be the fact that data with receptor agonists 
are less relevant than data with receptor antagonists with 
regard to the characterization of Hz-receptor subtypes 
(Bertaccini and Coruzzi 1983). Unfortunately, studies 
with Hz-antagonists on NADPH oxidase regulation are 
hampered by the fact that certain compounds containing 
imidazole structures, e.g. cimetidine, at concentrations 
above 10 gM per se may inhibit O2 formation, possibly 
due to interference with cytochrome b 245 (data not 
shown) (Ozaki et al. 1984; Iizuka et al. 1985). In addition, 
the guanidinothiazole, famotidine, at concentrations 
above 30 gM inhibits O2 formation (data not shown). 
The data for the Hz-agonistic activities of dimaprit 
and (R)-~-methylhistamine  neutrophils are in agree- 
ment with the ones for the guinea pig atrium (Parsons et 
al. 1977; Gerhard and Schunack 1980; Arranget al. 
1987). However, there are several dissociations between 
the effects of guanidines 1 -17  in these systems. First, 
guanidines i -  17 are all full agonists in the guinea pig 
atrium, but in the neutrophil, guanidines 1- 6, 16 and 17 
are only partial agonists. Second, guanidines 1 -17  are 
2-130-fold more potent han histamine in the guinea pig 
atrium. In contrast, in the neutrophil, guanidines 1, 4 -  
6 and 17 are less potent than histamine, and the other 
guanidines are only up to 2.5-fold as potent as histamine. 
Third, in the neutrophil but not in the guinea pig atrium, 
shortening or elongation of the carbon chain connecting 
the aromatic rings with the guanidine group in phenyl- 
(pyridylalkyl)guanidines 6 and 17 is associated with a 
decrease in intrinsic activity. In contrast, the order of 
potency of guanidines is similar in both model systems 
(6 < 7 -16  > 17). Fourth, in the guinea pig, the potency 
of phenyl(pyridylalkyl)guanidines is considerably in- 
creased by halogenation or by dihalogenation of the phe- 
nyl ring. In the neutrophil, halogenation of the phenyl 
ring slightly increases the intrinsic activity but not the 
potency of guanidines. Thus, structure/activity consider- 
ations for impromidine-like Hz-agonists in the guinea pig 
atrium reveal that these molecules may be varied in a 
wide range with considerable increase in potency and 
without decrease in intrinsic activity. In the neutrophil, 
however, the structural requirements of Hz-agonists ap- 
pear to be more stringent. Interestingly, the differences 
between both test models are much less pronounced for 
relatively small molecules, i.e. histamine, dimaprit and 
(R)-~-methylhistamine, and are more prominent for 
guanidines with bulky lipophilic groups, e.g. diarylalkyl 
substituents. 
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Recently, Mitsuhashi et al. (1989) reported that Hz- 
agonists activated both phospholipase C and adenylyl 
cyclase in differentiated HL-60 cells through cholera 
toxin-sensitive guanine nucleotide-binding proteins. His- 
taminergic stimulation of phospholipase C would be ex- 
pected to be associated with activation of NADPH oxi- 
dase (Rossi 1986), whereas histaminergic activation of 
adenylyl cyclase would lead to inhibition of O2 formation 
(Seligmann et al. 1983; Burde et al. 1989). Thus, the 
unique profile in potency and intrinsic activity of guani- 
dines on NADPH oxidase may be due to the fact that 
these compounds differentially activate stimulatory and 
inhibitory signal transduction pathways in neutrophils 
through Hi-receptors. Further studies will have to ad- 
dress this hypothesis n detail. 
The pA2 values for famotidine in the neutrophil also 
deserve attention. The pA2 values for famotidine in hu- 
man neutrophils amount o 6 .8-  7.5 and are lower than 
the pA2 values for famotidine in other systems (7.5- 
8.5) (see Fig. 2) (Schunack 1987; Burde et al. 1989). In 
addition, cimetidine at an equimolar concentration 
almost completely antagonized the effects of histamine 
and compound 8 on O2 formation, whereas the effects 
of the partial Hz-agonist, compound 3, and of the full 
agonists, guanidines 7, 10 and 11, were only partially 
antagonized by cimetidine (see Table 2). All these data 
support he concept hat He-receptors are heterogenous, 
and we suggest hat human neutrophils possess a cell- 
type specific subtype of Hz-receptors. Another interesting 
approach to characterize H2-receptors in the guinea pig 
atrium and in the neutrophil would be the comparison of 
the potencies of guanidines to elicit biological effects and 
their affinity in binding studies. In this context it may be 
interesting to note that neutrophil purino- and pyrimi- 
dinoceptors also possess structural requirements for 
agonists which are different from those of nucleotide 
receptors in other cell types (Seifert and Schultz 1989; 
Seifert et al. 1989c). 
However, other possibilities than H2-receptor sub- 
types to explain the differential effects of H2-agonists in 
the guinea pig atrium and in neutrophils cannot be ruled 
out. First, species-specificities of H2-receptors may con- 
tribute, at least in part, to these differences. Second, the 
receptor reserves for histamine and synthetic Hz-agonists 
may be different (Rising and Steward 1986). Third, the 
metabolism of H2-agonists may be different in the two 
systems. In addition, the tissue/cell type-specificity of the 
effects of H2-agonists may be due to physicochemical 
differences in the microenvironment of the affinity-con- 
ferring domains of Hz-receptors (Khan et al. 1987; 
Buschauer 1989). Furthermore, differences in the kinetics 
of distribution ~ of H2-agonists in the guinea pig atrium 
and in neutrophils may contribute to differences in the 
effects of compounds 1 - 17. For example, the inhibitory 
effect of arpromidine (9) in neutrophils i evident immedi- 
ately after its application (see Fig: 1), but in the guinea 
pig atrium, the effects of 9 are slow in onset (Buschauer 
1989). This difference may be due to the fact that unlike 
in an intact tissue, diffusion barriers do not limit the 
accessibility of compound 9 for H2-receptors in sus- 
pended neutrophils. Finally, it should be noted that in the 
guinea pig atrium, He-agonists per se exert stimulatory 
effects on the sinus node, whereas in the neutrophil Hz- 
agonists per se do not possess stimulatory effects but 
inhibit stimulated O~- formation. Thus, inhibition of 
fMet-Leu-Phe-induced O~ formation by H2-agonists is 
an indirect method to assess H2-receptors. 
Regardless of whether Hi-receptor subtypes are or 
are not involved in the differential ctivity of H2-agonists 
in the guinea pig atrium and in neutrophils, the relative 
selectivity of compounds 1 - 17 for cardiac tissue in com- 
parison to neutrophils may be of therapeutical relevance. 
For example, a positive inotropic effect of H2-agonists in 
congestive heart failure may be achieved without 
compromising O~- formation and hence the function of 
neutrophils in host defense. Conversely, our data raise 
the possibility that neutrophil-specific H2-agonists may 
be developed. Inhibition of neutrophil functions by H2- 
agonists may be of therapeutical value in a variety of 
pathological conditions associated with neutrophil acti- 
vation, e.g. myocardial infarction, rheumatoid arthritis 
and nephritis (Malech and Gallin ~ 987). 
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